[1] KASKI J C, CREA F, GERSH B J, et al. Reappraisal of ischemic heart disease[J]. Circulation, 2018, 138(14): 1463-1480. [2] DEL BUONO M G, MONTONE R A, CAMILLI M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 78(13): 1352-1371. [3] MITTAL S R. Diagnosis of coronary microvascular dysfunction - present status[J]. Indian Heart J, 2015, 67(6): 552-560. [4] PIEGZA M, WIERZBA D, PIEGZA J. Cardiac syndrome X - the present knowledge[J]. Psychiatr Pol, 2021, 55(2): 363-375. [5] AZEEZ T A. Osteoporosis and cardiovascular disease: a review[J]. Mol Biol Rep, 2023, 50(2): 1753-1763. [6] LANZA G A, CREA F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management[J]. Circulation, 2010, 121(21): 2317-2325. [7] KASKI J C. Cardiac syndrome X in women: the role of oestrogen deficiency[J]. Heart, 2006, 92(Suppl 3): iii5-iii9. [8] MARINESCU M A, LÖFFLER A I, OUELLETTE M, et al. Coronary microvascular dysfunction, microvascular angina, and treatment strategies[J]. JACC Cardiovasc Imaging, 2015, 8(2): 210-220. [9] SCHIAVI J, FODERA D M, BRENNAN M A, et al. Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro[J]. Exp Cell Res, 2021, 408(1): 112814. [10] NACHTIGALL M, NACHTIGALL L. Update on estrogen therapy and prevention of bone loss[J]. Menopause, 2023, 30(6): 567-568. [11] 苟静,岳建彪,李霞.70岁以上老年人群骨质疏松症与心血管疾病危险因素的关系研究[J]. 中国医学前沿杂志:电子版, 2021, 13(5): 70-73. [12] REYES-GARCÍA R, ROZAS-MORENO P, MUÑOZ-TORRES M. Cardiovascular disease and bone metabolism[J]. Endocrinol Nutr, 2011, 58(7): 353-359. [13] VASSALLE C, SABATINO L, CECCO P D, et al. Relationship between bone health biomarkers and cardiovascular risk in a general adult population[J]. Diseases, 2017, 5(4): 24. [14] 张萌萌, 张秀珍, 邓伟民, 等. 骨代谢生化指标临床应用专家共识(2020)[J]. 中国骨质疏松杂志, 2020, 26(6): 781-796. [15] HAARHAUS M, CIANCIOLO G, BARBUTO S, et al. Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease[J]. Nutrients, 2022, 14(10): 2124. [16] 卢锋, 陈海啸. 骨质疏松中不同炎症因子的研究进展[J]. 临床医学进展, 2022, 12 (4): 2590-2604. [17] TACEY A, HAYES A, ZULLI A, et al. Osteocalcin and vascular function: is there a cross-talk? [J]. Mol Metab, 2021, 49: 101205. |